BioSpace News Archive

Genetown

Orchard Therapeutics Presents an Integrated Data Analysis Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of Metachromatic Leukodystrophy

Orchard Therapeutics announced results from an integrated data analysis of OTL-200, a gene therapy in development for the treatment of metachromatic leukodystrophy (MLD) at the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy.

September 5, 2019
·
10 min read
Genetown

MassBio® Inaugural Digital Health Impact 2019 Event to Explore Convergence Between Digital Tech & the Life Sciences

Part of Biotech Week Boston, the event brings together influencers in digital health and drug discovery & development

September 5, 2019
·
2 min read
Policy

CDC Awarding Opioid Misuse Prevention Grants Directly to Local Health Departments for the First Time

The Centers for Disease Control and Prevention announced the recipients of its Overdose Data to Action grants, including those in 17 local jurisdictions.

September 5, 2019
·
3 min read
Deals

MilliporeSigma Acquires Data Management and Analysis Platform for Biopharma Real-Time Process Monitoring and Reporting

MilliporeSigma has acquired all ownership rights to the ProcessPad™ platform from Simplyfeye Softwares Private Limited. The agreement includes the transfer of all copyrights and relevant intellectual property related to this software platform.

September 5, 2019
·
1 min read
Genetown

Summit Presented In Vivo Proof of Concept Data for Targeted Enterobacteriaceae Antibiotics at ASM/ESCMID Conference

Summit Therapeutics plc presented in vivo proof of concept data for its targeted Enterobacteriaceae antibiotics in animal models of sepsis, pneumonia and urinary tract infection.

September 5, 2019
·
7 min read
Job Trends

Bristol-Meyers Squibb, Boehringer Ingelheim and Other Biotechnology Companies to Present Use of Carterra’s Next Generation Antibody Screening Technology at Symposia Across the US and Europe

The Therapeutic Antibody Revolution in the Post Genomics Era: Using High Throughput SPR to Explore the Full Kinetic and Epitope Diversity of Antibody Libraries Supporting mAb, CAR-T, Bispecifics and ADC Therapeutic Discovery

September 5, 2019
·
3 min read
BioMidwest

Esperion Completes Patient Enrollment in the Global CLEAR Cardiovascular Outcomes Trial for Bempedoic Acid

Esperion announced the completion of patient enrollment in the CLEAR Cardiovascular Outcomes Trial.

September 5, 2019
·
9 min read
Drug Development

The Show Must Go On: Bristol-Myers Continues Brain Cancer Trial After Missing One Co-Primary Endpoint

The data monitoring committee recommended the trial continue as planned, with an estimated primary completion date in February 2022.

September 5, 2019
·
2 min read
·
Mark Terry
Policy

Mallinckrodt Taps Restructuring Advisers Ahead of Opioid Lawsuit in Ohio

Shares of Mallinckrodt are down more than 45% in premarket trading after multiple reports indicate the company plans a restructuring in the wake of the opioid crisis that has promoted a number of lawsuits that implicate the company for its sales practices in the United States.

September 5, 2019
·
2 min read
·
Alex Keown
Business

BioSpace Movers & Shakers, Sept. 6

Biopharma companies strengthen the C-suite and board of directors with these appointments.

September 5, 2019
·
7 min read
·
Alex Keown